Sudarshan Chemical Industries (506655) Q1 24/25 earnings summary

Executive summary

• Achieved highest ever operative revenue and EBITDA in FY24, with sales growing at a 10% CAGR and operating profit at 11% CAGR since FY11, reflecting a focused pigment business strategy.

• Unaudited standalone and consolidated financial results for the quarter ended 30 June 2024 were approved by the Board on 2 August 2024.

• Exported to 85+ countries, maintaining leadership in the pigment segment and expanding global reach.

• The review reports from statutory auditors confirm compliance with Indian Accounting Standards and SEBI regulations, with no material misstatements identified.

Financial highlights

• Q1 FY25 consolidated income from operations rose 4% year-over-year to ₹634 Cr.

• EBITDA for Q1 FY25 increased 16% year-over-year to ₹81 Cr, with margin at 12.7%.

• PAT for Q1 FY25 was ₹29 Cr, up 38% year-over-year, with margin at 4.6%.

• Earnings per share (consolidated, before exceptional items) for Q1 FY25 was ₹4.3, compared to ₹3.0 in Q1 FY24.

• Standalone revenue from operations for Q1 FY25 was ₹57,282.4 lakhs, up from ₹51,894.7 lakhs in Q1 FY24.

Outlook and guidance

• Capex program underway to drive future growth and EBITDA improvement, with a focus on expanding the specialty segment and product portfolio.

• Continued emphasis on sustainability, operational efficiency, and deeper penetration in international markets.

• Return on Capital Employed improvement remains a key initiative.

• The Board recommended a final dividend of ₹1.00 per share for FY24, in addition to the interim dividend of ₹3.60 per share, totaling ₹4.60 per share for the year.